{"id":"https://openalex.org/W4401029441","doi":"https://doi.org/10.1111/all.16256","title":"Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study","display_name":"Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study","publication_year":2024,"publication_date":"2024-07-26","ids":{"openalex":"https://openalex.org/W4401029441","doi":"https://doi.org/10.1111/all.16256","pmid":"https://pubmed.ncbi.nlm.nih.gov/39056480"},"language":"en","primary_location":{"id":"doi:10.1111/all.16256","doi":"https://doi.org/10.1111/all.16256","is_oa":true,"landing_page_url":"https://doi.org/10.1111/all.16256","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.16256","source":{"id":"https://openalex.org/S68090385","display_name":"Allergy","issn_l":"0105-4538","issn":["0105-4538","1398-9995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.16256","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025255297","display_name":"G. Pierrard","orcid":"https://orcid.org/0009-0009-2534-6976","observed_orcids":["https://orcid.org/0009-0009-2534-6976"]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Guillaume Pierrard","raw_affiliation_strings":["CHU Lille, University Lille, Service de Dermatologie, Lille, France"],"raw_orcid":"https://orcid.org/0009-0009-2534-6976","affiliations":[{"raw_affiliation_string":"CHU Lille, University Lille, Service de Dermatologie, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I3018718406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030754827","display_name":"Claire Bernier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Claire Bernier","raw_affiliation_strings":["CHU Nantes, Service de Dermatologie, Nantes, France","French Chronic Urticaria Study Group (GUS), Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Nantes, Service de Dermatologie, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039942129","display_name":"Aur\u00e9lie Du-Thanh","orcid":"https://orcid.org/0000-0003-1508-1977","observed_orcids":["https://orcid.org/0000-0003-1508-1977"]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Aur\u00e9lie Du\u2010Thanh","raw_affiliation_strings":["CHU Montpellier, Service de Dermatologie, Montpellier, France","French Chronic Urticaria Study Group (GUS), Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Montpellier, Service de Dermatologie, Montpellier, France","institution_ids":["https://openalex.org/I4210093292"]},{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112707443","display_name":"C. Bara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125982","display_name":"Centre Hospitalier du Mans","ror":"https://ror.org/03bf2nz41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210125982"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Corina Bara","raw_affiliation_strings":["CHU Le Mans, Service de Dermatologie, Le Mans, France","French Chronic Urticaria Study Group (GUS), Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Le Mans, Service de Dermatologie, Le Mans, France","institution_ids":["https://openalex.org/I4210125982"]},{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039952610","display_name":"Ang\u00e8le Soria","orcid":"https://orcid.org/0000-0002-8726-6658","observed_orcids":["https://orcid.org/0000-0002-8726-6658"]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210166768","display_name":"H\u00f4pital Tenon","ror":"https://ror.org/05h5v3c50","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166768"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ang\u00e8le Soria","raw_affiliation_strings":["French Chronic Urticaria Study Group (GUS), Paris, France","Sorbonne Universit\u00e9 Service de Dermatologie et d'Allergologie, H\u00f4pital Tenon  Paris France"],"raw_orcid":"https://orcid.org/0000-0002-8726-6658","affiliations":[{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]},{"raw_affiliation_string":"Sorbonne Universit\u00e9 Service de Dermatologie et d'Allergologie, H\u00f4pital Tenon  Paris France","institution_ids":["https://openalex.org/I39804081","https://openalex.org/I4210166768"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030782481","display_name":"Florence Castelain","orcid":"https://orcid.org/0000-0003-0334-8486","observed_orcids":["https://orcid.org/0000-0003-0334-8486"]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Castelain","raw_affiliation_strings":["CHU Besan\u00e7on Service de Dermatologie  Besan\u00e7on France","French Chronic Urticaria Study Group (GUS), Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Besan\u00e7on Service de Dermatologie  Besan\u00e7on France","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066356763","display_name":"Isabelle Boccon\u2010Gibod","orcid":"https://orcid.org/0000-0002-5774-8429","observed_orcids":["https://orcid.org/0000-0002-5774-8429"]},"institutions":[{"id":"https://openalex.org/I2800555055","display_name":"Centre Hospitalier Universitaire de Grenoble","ror":"https://ror.org/041rhpw39","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2800555055"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Boccon\u2010Gibod","raw_affiliation_strings":["CHU Grenoble, Service de M\u00e9decine Interne et Immunologie Clinique Centre de Reference des Angi\u0153d\u00e8mes  Grenoble France","French Chronic Urticaria Study Group (GUS), Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Grenoble, Service de M\u00e9decine Interne et Immunologie Clinique Centre de Reference des Angi\u0153d\u00e8mes  Grenoble France","institution_ids":["https://openalex.org/I2800555055"]},{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070199676","display_name":"Florence Hacard","orcid":"https://orcid.org/0000-0001-8300-1233","observed_orcids":["https://orcid.org/0000-0001-8300-1233"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Hacard","raw_affiliation_strings":["CHU Lyon, Service Allergologie et Immunologie Clinique, Lyon, France","French Chronic Urticaria Study Group (GUS), Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Lyon, Service Allergologie et Immunologie Clinique, Lyon, France","institution_ids":["https://openalex.org/I4210100596"]},{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003017510","display_name":"Juliette Delaunay","orcid":"https://orcid.org/0000-0003-4996-8912","observed_orcids":["https://orcid.org/0000-0003-4996-8912"]},"institutions":[{"id":"https://openalex.org/I4210112910","display_name":"Centre Hospitalier Universitaire d'Angers","ror":"https://ror.org/0250ngj72","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210112910"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Juliette Delaunay","raw_affiliation_strings":["CHU Angers, Service de Dermatologie Angers, Angers, France","French Chronic Urticaria Study Group (GUS), Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Angers, Service de Dermatologie Angers, Angers, France","institution_ids":["https://openalex.org/I4210112910"]},{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017442709","display_name":"Laurence de Montjoye","orcid":"https://orcid.org/0000-0003-0673-0728","observed_orcids":["https://orcid.org/0000-0003-0673-0728"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]},{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Laurence de\u00a0Montjoye","raw_affiliation_strings":["Department of Dermatology, Cliniques Universitaires Saint\u2010Luc Universit\u00e9 Catholique de Louvain  Brussels Belgium","French Chronic Urticaria Study Group (GUS), Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Cliniques Universitaires Saint\u2010Luc Universit\u00e9 Catholique de Louvain  Brussels Belgium","institution_ids":["https://openalex.org/I1315288073","https://openalex.org/I95674353"]},{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043652725","display_name":"Delphine Staumont-Sall\u00e9","orcid":"https://orcid.org/0000-0002-4780-4212","observed_orcids":["https://orcid.org/0000-0002-4780-4212"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4387152267","display_name":"Institute for Translational Research in Inflammation","ror":"https://ror.org/03qy9z186","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4387152267"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Delphine Staumont\u2010Salle","raw_affiliation_strings":["CHU Lille, University Lille, Service de Dermatologie, Lille, France","French Chronic Urticaria Study Group (GUS), Paris, France","U1286 Inserm INFINITE Institute for Translational Research in Inflammation, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Lille, University Lille, Service de Dermatologie, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I3018718406"]},{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]},{"raw_affiliation_string":"U1286 Inserm INFINITE Institute for Translational Research in Inflammation, Lille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387152267"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041554015","display_name":"Fr\u00e9d\u00e9ric Dezoteux","orcid":"https://orcid.org/0000-0001-8930-1042","observed_orcids":["https://orcid.org/0000-0001-8930-1042"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4387152267","display_name":"Institute for Translational Research in Inflammation","ror":"https://ror.org/03qy9z186","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4387152267"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fr\u00e9d\u00e9ric Dezoteux","raw_affiliation_strings":["CHU Lille, University Lille, Service de Dermatologie, Lille, France","French Chronic Urticaria Study Group (GUS), Paris, France","U1286 Inserm INFINITE Institute for Translational Research in Inflammation, Lille, France"],"raw_orcid":"https://orcid.org/0000-0001-8930-1042","affiliations":[{"raw_affiliation_string":"CHU Lille, University Lille, Service de Dermatologie, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I3018718406"]},{"raw_affiliation_string":"French Chronic Urticaria Study Group (GUS), Paris, France","institution_ids":[]},{"raw_affiliation_string":"U1286 Inserm INFINITE Institute for Translational Research in Inflammation, Lille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387152267"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":15,"corresponding_author_ids":["https://openalex.org/A5025255297"],"corresponding_institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I3018718406"],"apc_list":{"value":5150,"currency":"USD","value_usd":5150},"apc_paid":{"value":5150,"currency":"USD","value_usd":5150},"fwci":3.2198,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.92164749,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"79","issue":"9","first_page":"2448","last_page":"2457"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12600","display_name":"Eosinophilic Disorders and Syndromes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":1.0},{"id":"https://openalex.org/keywords/chronic-spontaneous-urticaria","display_name":"chronic spontaneous urticaria","score":0.9789999723434448},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6330000162124634},{"id":"https://openalex.org/keywords/predictive-factors","display_name":"predictive factors","score":0.7319999933242798},{"id":"https://openalex.org/keywords/injection-frequency","display_name":"injection frequency","score":0.6110000014305115},{"id":"https://openalex.org/keywords/lymphocyte-count","display_name":"lymphocyte count","score":0.8240000009536743},{"id":"https://openalex.org/keywords/serum-ige","display_name":"serum IgE","score":0.890999972820282},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.47699999809265137},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7710000276565552},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.9469486474990845},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.7892825603485107},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7786800861358643},{"id":"https://openalex.org/C3017745231","wikidata":"https://www.wikidata.org/wiki/Q187440","display_name":"Chronic urticaria","level":2,"score":0.676647424697876},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5164859294891357},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4598568081855774},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4279943108558655},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.3279680013656616},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3146809935569763},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2748437821865082},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.22021567821502686}],"mesh":[{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000080223","descriptor_name":"Chronic Urticaria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1111/all.16256","doi":"https://doi.org/10.1111/all.16256","is_oa":true,"landing_page_url":"https://doi.org/10.1111/all.16256","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.16256","source":{"id":"https://openalex.org/S68090385","display_name":"Allergy","issn_l":"0105-4538","issn":["0105-4538","1398-9995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"journal-article"},{"id":"doi:10.22541/au.171375616.63771208/v1","doi":"https://doi.org/10.22541/au.171375616.63771208/v1","is_oa":true,"landing_page_url":"https://doi.org/10.22541/au.171375616.63771208/v1","pdf_url":"https://www.authorea.com/doi/pdf/10.22541/au.171375616.63771208","source":null,"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmid:39056480","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39056480","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-05284872v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-05284872","pdf_url":"https://hal.science/hal-05284872v1/file/Allergy%20-%202024%20-%20Pierrard%20-%20Characterization%20of%20omalizumab%20updosing%20patterns%20and%20predictive%20factors%20in%20chronic%20spontaneous.pdf","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Allergy, 2024, 79, pp.2448 - 2457. &#x27E8;10.1111/all.16256&#x27E9;","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:HAL:hal-04948917v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-04948917","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Allergy, 2024, 79 (9), pp.2448-2457. &#x27E8;10.1111/all.16256&#x27E9;","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:291675","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2078.1/291675","pdf_url":null,"source":{"id":"https://openalex.org/S4306401902","display_name":"Digital Access to Libraries (Universit\u00e9 catholique de Louvain (UCL), l'Universit\u00e9 de Namur (UNamur) and the Universit\u00e9 Saint-Louis (USL-B))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I95674353","host_organization_name":"UCLouvain","host_organization_lineage":["https://openalex.org/I95674353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Allergy, Vol. 79, no.9, p. 2448-2457 (2024)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:lilloa.univ-lille.fr:20.500.12210/129587","doi":null,"is_oa":false,"landing_page_url":"https://lilloa.univ-lille.fr/handle/20.500.12210/129587","pdf_url":null,"source":{"id":"https://openalex.org/S4306402203","display_name":"LillOA (Universit\u00e9 de Lille (University Of Lille))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210123514","host_organization_name":"Centre d'\u00c9tudes en Civilisations, Langues et Lettres \u00c9trang\u00e8res","host_organization_lineage":["https://openalex.org/I4210123514"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/all.16256","doi":"https://doi.org/10.1111/all.16256","is_oa":true,"landing_page_url":"https://doi.org/10.1111/all.16256","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.16256","source":{"id":"https://openalex.org/S68090385","display_name":"Allergy","issn_l":"0105-4538","issn":["0105-4538","1398-9995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401029441.pdf","grobid_xml":"https://content.openalex.org/works/W4401029441.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W2026119244","https://openalex.org/W2057677742","https://openalex.org/W2151135346","https://openalex.org/W2172080971","https://openalex.org/W2594418615","https://openalex.org/W2888422117","https://openalex.org/W2890323318","https://openalex.org/W2901940756","https://openalex.org/W2901989064","https://openalex.org/W2916332141","https://openalex.org/W2947879370","https://openalex.org/W2952630148","https://openalex.org/W2955002450","https://openalex.org/W2959650581","https://openalex.org/W2970721464","https://openalex.org/W2986553189","https://openalex.org/W3011098445","https://openalex.org/W3022640803","https://openalex.org/W3025104320","https://openalex.org/W3034990624","https://openalex.org/W3039271871","https://openalex.org/W3087522660","https://openalex.org/W3128675847","https://openalex.org/W3185967979","https://openalex.org/W3200862524","https://openalex.org/W4200204223","https://openalex.org/W4213205248","https://openalex.org/W4280492615","https://openalex.org/W4293072745","https://openalex.org/W4318323660","https://openalex.org/W4321434442","https://openalex.org/W4361265337","https://openalex.org/W4362589091","https://openalex.org/W4366392237","https://openalex.org/W4378839878","https://openalex.org/W4381952162","https://openalex.org/W4384038400","https://openalex.org/W4386201153","https://openalex.org/W4386247323"],"related_works":["https://openalex.org/W4386201153","https://openalex.org/W3025104320","https://openalex.org/W2888422117","https://openalex.org/W4391535094","https://openalex.org/W7213542710","https://openalex.org/W2984954948","https://openalex.org/W2943438248","https://openalex.org/W2793609975","https://openalex.org/W4400125661","https://openalex.org/W3127841053"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Limited":[2],"information":[3],"is":[4,226],"available":[5],"on":[6],"the":[7,35,50,65,108,153,161,168],"use":[8],"of":[9,38,52,110,122,129,141,163,205,232],"omalizumab":[10],"(OMA)":[11],"updosing":[12,54,112,219,225],"since":[13],"its":[14],"introduction":[15],"as":[16,56],"a":[17,79,185],"second\u2010line":[18],"therapy":[19],"in":[20,25,58,150,215,228,230],"chronic":[21],"spontaneous":[22],"urticaria":[23],"(CSU)":[24],"2014.":[26],"Practical":[27],"guidelines":[28],"from":[29],"health":[30],"authorities":[31],"are":[32],"lacking,":[33],"and":[34,71,90,101,126,132,148,193,235],"specific":[36],"characteristics":[37],"patients":[39,86,142,170],"requiring":[40],"higher":[41],"doses":[42],"remain":[43],"unknown.":[44],"Our":[45],"objectives":[46],"were":[47,95,143,171,207],"to":[48,63,72,159,174],"characterize":[49],"patterns":[51],"OMA":[53,111,130,206,224],"(defined":[55],"changes":[57],"dose":[59],"and/or":[60],"injection":[61],"intervals),":[62],"identify":[64],"predictive":[66],"factors":[67],"associated":[68],"with":[69,88],"updosing,":[70],"improve":[73],"CSU":[74,89,178],"management.":[75],"Methods":[76],"We":[77,135],"conducted":[78],"prospective,":[80],"multicentric,":[81],"real\u2010life":[82],"observational":[83],"study,":[84],"including":[85],"diagnosed":[87],"starting":[91],"OMA.":[92],"The":[93,104,116,202],"data":[94],"collected":[96],"at":[97,113,145],"0,":[98],"3,":[99],"6,":[100],"9":[102],"months.":[103,115,223],"primary":[105],"endpoint":[106],"was":[107],"frequency":[109,162],"3":[114,146,222],"secondary":[117],"endpoints":[118],"included":[119,136],"an":[120,127],"analysis":[121],"updosed":[123,144,169],"patients'":[124],"profile,":[125],"assessment":[128],"efficacy":[131],"safety.":[133],"Results":[134],"153":[137],"patients.":[138],"Twenty":[139],"percent":[140],"months,":[147],"27%":[149],"total":[151],"during":[152],"9\u2010month":[154],"follow\u2010up.":[155],"Practitioners":[156],"mainly":[157],"chose":[158],"increase":[160],"injections":[164],"(66%).":[165],"At":[166],"baseline,":[167],"more":[172,176,209],"likely":[173],"have":[175],"severe":[177,233],"(UCT":[179],"<":[180,183],"4,":[181],"p":[182,190,199],"0.030),":[184],"lower":[186],"lymphocyte":[187],"count":[188],"(<2000/mm3,":[189],"=":[191,200],"0.037),":[192],"low":[194,236],"IgE":[195,237],"levels":[196],"(<70":[197],"UI/mL,":[198],"0.024).":[201],"side":[203],"effects":[204],"not":[208],"frequent":[210,227],"after":[211],"updosing.":[212],"Conclusion":[213],"One":[214],"five":[216],"patient":[217],"underwent":[218],"within":[220],"just":[221],"particular":[229],"cases":[231],"disease":[234],"blood":[238],"levels.":[239]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-07-27T00:00:00"}